HK이노엔

195940KOSDAQ

57.8 / 100

Reference Date: 2026-09-08

Financial Score25.5 / 40

News Sentiment17.3 / 25

Momentum8.0 / 20

Disclosure7.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Slightly down 1.7% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HK Inoent is a pharmaceutical company primarily engaged in ETC (Specialty Pharmaceuticals) and H&B (Health & Beauty) businesses, achieving sales of 1.632 trillion KRW and operating profit of 110.9 billion KRW in 2025 through key products like K-Cap and H&B items such as Condition. Established in 1984, the company expanded through the acquisition of Hanil Pharm in 2006 and Hanacolma in 2018, focusing on R&D and global market expansion.

Number of Employees

1,723people

Average Salary

84.6M KRW

Score Calculation Basis

Detailed Financial Score

PER

15.31Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR

0.87Industry Average 1.205.5Point

Lower than industry avg (good)

ROE

5.87Industry Average 8.002.5Point

Below industry avg

Debt Ratio

13.25Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20256.5 / 10 points

Revenue Growth Rate

2.5 / 3

Avg ▲13.4% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲29.8% (2-year basis)

ROE Trend

1.0 / 4

Avg ROE 5.0% (improving, 3yr)

Detailed News Sentiment

11 totalPositive 6Neutral 5Negative 0Average Sentiment Score 69.1

Neutral
오늘은 ‘기술개발인의 날’…삼성·SK하이닉스 연구자 등 포상
Neutral
"술 먹고 다음날 해장?" 이젠 옛말…2030 꼭 챙긴다는 '이것' [...
The trend towards reducing alcohol consumption is noted but does not directly impact HK이노엔's primary product line.
Positive
온코닉테라퓨틱스 '자큐보', 헬리코박터 제균 임상 3상 IND 승인
HK이노엔 관련 직접적 영향 없음: 온코닉테라퓨틱스의 자큐보 임상 성공으로 헬리코박터 치료 시장 확대 기대.

Detailed Momentum

52-week position3.0Point

52w lower range (26%)

Current 40,900Won52-week high 57,60052-week low 34,900

1-month return3.0Point

1m -1.68% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 4Negative 1

Neutral대규모기업집단현황공시[분기별공시(개별회사용)]2026-08-28
Neutral반기보고서 (2026.06)2026-08-14
Negative지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항2026-08-14
Neutral독립이사의선임ㆍ해임또는중도퇴임에관한신고2026-08-12
Neutral임시주주총회결과2026-08-12